Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions. (2022)
Attributed to:
AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.7326/m22-0281
PubMed Identifier: 35226530
Publication URI: http://europepmc.org/abstract/MED/35226530
Type: Journal Article/Review
Volume: 175
Parent Publication: Annals of internal medicine
Issue: 5
ISSN: 0003-4819